Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak

Core Points - Theratechnologies Inc. has received final court approval for its plan of arrangement involving CB Biotechnology, LLC, an affiliate of Future Pak, LLC [1] - The arrangement was previously approved by the shareholders at a special meeting held on September 12, 2025 [1] - The company anticipates that the arrangement will be completed around September 25, 2025, pending the satisfaction of remaining closing conditions [2] Company Overview - Theratechnologies is a commercial-stage biopharmaceutical company focused on innovative therapies that aim to redefine standards of care [3] - The company is listed on both the TSX and NASDAQ under the ticker symbols TH and THTX, respectively [3] Future Pak Overview - Future Pak, established in 1977 and based in Wixom, Michigan, is a privately held contract manufacturer, packager, and distributor of pharmaceutical and nutraceutical products [4] - The company operates across various markets, including retail, specialty, and institutional, leveraging its infrastructure and partner network to provide quality-first, patient-centric solutions [4]